Non-intrusive Detection of Temporary Neurologic Impairment By Opioids

NCT04223609 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Oxycodone
DRUG: Placebo
DEVICE: EyeLink 1000 Plus
DIAGNOSTIC_TEST: Oculo-Cognitive Addition test (OCAT)
DEVICE: VT3mini - Eye Tracking Technology for OEMs

Sponsor

Mayo Clinic